Work

Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.

Year: 2003

Type: article

Study design: Observational Study

Source: PubMed

Authors: Andre T Baron, Elsa M Cora, Jacqueline M Lafky, Cecelia H Boardman, Marites C Buenafe, Alfred Rademaker, Dachao Liu, David A Fishman, Karl C Podratz, Nita J Maihle

Institution: Mayo Clinic

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: SOLUBLE ERBB1 MOLECULES AS TUMOR BIOMARKERS, CIRCULATING SERBB1 LEVELS AS DIAGNOSTIC TUMOR BIOMARKERS, THE NATIONAL OVARIAN CANCER EARLY DETECTION PROGRAM, SEROLOGIC SERBBL IN HEALTHY WOMEN, IDENTIFICATION OF ERES IN THE AMPHIREGULIN GENE

OpenAlex ID: W2117535216

FWCI: 4.678

Cites: 77

Cited by: 97

Related to: 10